Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 79
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Lupus ; 27(3): 461-467, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28799839

RESUMEN

We investigated renal outcome of kidney-transplantation in 19 Korean recipients with biopsy-proven lupus nephritis and compared it with 18 Korean age- and gender-matched recipients without lupus nephritis who were diagnosed with end-stage renal disease caused by renal diseases other than lupus nephritis in a single centre. We reviewed histological findings of kidneys and calculated cumulative dose of immunosuppressive agents. We assessed renal flare of systemic lupus erythematosus, recurrence of lupus nephritis and graft failure as prognosis. The mean age of recipients with lupus nephritis was 43.5 years and all patients were female. Six patients had class III, 10 had class IV and three had class V. There were no meaningful differences in demographic data, renal replacement modality, cumulative doses of immunosuppressants and prognosis between recipients with and without lupus nephritis. Eight patients experienced renal flare of systemic lupus erythematosus, but there were no cases of recurrence of lupus nephritis or graft failure in recipients with lupus nephritis. Kidney-recipients with class IV lupus nephritis exhibited a lower cumulative renal flare of systemic lupus erythematosus free survival rate than those with class III lupus nephritis. In conclusion, renal outcome of kidney-transplantation in patients with lupus nephritis is similar to that in those without lupus nephritis, and class IV was associated with renal flare of systemic lupus erythematosus.


Asunto(s)
Inmunosupresores/uso terapéutico , Fallo Renal Crónico/terapia , Trasplante de Riñón/efectos adversos , Riñón/fisiopatología , Nefritis Lúpica/terapia , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Fallo Renal Crónico/etiología , Nefritis Lúpica/complicaciones , Persona de Mediana Edad , Pronóstico , Recurrencia , República de Corea , Estudios Retrospectivos , Tasa de Supervivencia
2.
Child Care Health Dev ; 44(1): 140-146, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-28929518

RESUMEN

PURPOSE: The Communication Function Classification System (CFCS) and Viking Speech Scale (VSS) are useful systems for describing the broad communication function and speech intelligibility, respectively, of children with cerebral palsy (CP). The aims of this study were to determine the reliability and validity of the Korean version of the CFCS and also to investigate the association between the CFCS and the VSS and other functional classifications for children with CP. MATERIALS AND METHODS: Participants were 50 children with CP (33 males, 17 females; mean age 7.2 years, range 4-16 years) recruited from a rehabilitation hospital. We analysed the interrater and intrarater reliabilities of the Korean version of the CFCS and VSS between parents, a physiatrist, and a speech-language pathologist (SLP). The social function domain of the Paediatric Evaluation of Disability Inventory was assessed to examine the concurrent validity of the CFCS and VSS. RESULTS: The intrarater reliabilities of the CFCS and VSS were excellent in a physiatrist (ƙ = 0.92, ƙ = 0.94, respectively) and an SLP (ƙ = 0.98, ƙ = 0.98) and very good in parents (ƙ = 0.87, ƙ = 0.89). The interrater reliability of the CFCS and VSS was very good between the physiatrist and SLP (ƙ = 0.87, ƙ = 0.89) and good between parents and the SLP (ƙ = 0.63, ƙ = 0.78) and between parents and the physiatrist (ƙ = 0.61, ƙ = 0.76). The CFCS and VSS were strongly related with the social function domain of Paediatric Evaluation of Disability Inventory. In addition, we found very strong associations between the VSS and CFCS. CONCLUSIONS: The Korean version of the CFCS is a valid and reliable tool to classify communication ability and is strongly associated with the VSS, a reliable tool to classify speech intelligibility.


Asunto(s)
Parálisis Cerebral/complicaciones , Trastornos de la Comunicación/diagnóstico , Trastornos de la Comunicación/etiología , Pruebas del Lenguaje/normas , Adolescente , Parálisis Cerebral/clasificación , Parálisis Cerebral/fisiopatología , Niño , Preescolar , Trastornos de la Comunicación/fisiopatología , Estudios Transversales , Evaluación de la Discapacidad , Femenino , Humanos , Lenguaje , Masculino , Estudios Prospectivos , Reproducibilidad de los Resultados , República de Corea , Índice de Severidad de la Enfermedad , Inteligibilidad del Habla
3.
Vet Pathol ; 51(6): 1151-64, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24448672

RESUMEN

The pathogenesis of necrotizing meningoencephalitis (NME), necrotizing leukoencephalitis (NLE), and granulomatous meningoencephalomyelitis (GME) is still uncertain, although they are considered immune-mediated diseases. The purpose of the present study is to generate a rodent model(s) of these diseases. Rats were injected with rat cerebral or cerebellar homogenate. Rats injected with cerebral homogenate (Cbr) exhibited vacuolar or malacic changes mainly in the cerebral cortex. CD3-positive T cells and Iba-1-positive and CD163-negative microglia infiltrated and activated around the lesions. IgG deposited in the glial fibrillary acid protein (GFAP)-positive glia limitans from the early phase, and CD3-positive T cells attached to GFAP-positive astrocytes. Autoantibodies against GFAP were detected in the sera. These pathological features of Cbr rats were consistent with those of canine NME. In contrast, rats injected with cerebral homogenate (Cbe) exhibited demyelinating lesions with inflammatory reactions in the cerebellum, brainstem, and spinal cord. The presence of demyelination and autoantibodies against myelin proteins in Cbe rats was similar to murine experimental autoimmune encephalitis and differed from NME, NLE, and GME. All the present findings indicate that autoantibodies together with microglia and T cells may play a major role in the pathogenesis of idiopathic canine meningoencephalomyelitis.


Asunto(s)
Autoanticuerpos/inmunología , Enfermedades de los Perros/patología , Meningoencefalitis/veterinaria , Animales , Astrocitos/patología , Encéfalo/patología , Modelos Animales de Enfermedad , Enfermedades de los Perros/inmunología , Perros , Inflamación/veterinaria , Masculino , Meningoencefalitis/inmunología , Meningoencefalitis/patología , Vaina de Mielina/inmunología , Necrosis/veterinaria , Ratas , Ratas Endogámicas Lew , Linfocitos T/inmunología
4.
Eur J Neurol ; 20(8): 1161-9, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23551657

RESUMEN

BACKGROUND AND PURPOSE: We investigated the effect of celecoxib, a selective inhibitor of cyclo-oxygenase 2, in patients with intracerebral hemorrhage (ICH). METHODS: We conducted a multicenter, randomized, controlled, and open with blinded end-point trial of 44 Korean patients 18 years or older with ICH within 24 h of onset. The intervention group (n = 20) received celecoxib (400 mg twice a day) for 14 days. The control group (n = 24) received the standard medical treatment for ICH. The primary end-point was the number of patients with a change in the volume of perihematomal edema (PHE) from the 1st to the 7th ± 1 day (cut-off value, 20%). RESULTS: The time from onset to computed tomography scan slightly differed between groups (177 ± 160 min for control vs. 297 ± 305 min for the celecoxib group; P = 0.10). In the primary end-point analysis using cut-off values, there was a significant shift to reduced expansion of PHE in the celecoxib group (P = 0.005). With respect to the secondary end-points, there was also a significant shift to reduced expansion of ICH in the celecoxib group (P = 0.046). In addition, the expansion rate of PHE at follow-up tended to be higher in the control group than in the celecoxib group (90.6 ± 91.7% vs. 44.4 ± 64.9%; P = 0.058). CONCLUSIONS: In our small, pilot trial, administration of celecoxib in the acute stage of ICH was associated with a smaller expansion of PHE than that observed in controls.


Asunto(s)
Edema Encefálico/tratamiento farmacológico , Hemorragia Cerebral/tratamiento farmacológico , Inhibidores de la Ciclooxigenasa 2/uso terapéutico , Pirazoles/uso terapéutico , Sulfonamidas/uso terapéutico , Anciano , Anciano de 80 o más Años , Edema Encefálico/patología , Edema Encefálico/cirugía , Celecoxib , Hemorragia Cerebral/patología , Hemorragia Cerebral/cirugía , Inhibidores de la Ciclooxigenasa 2/efectos adversos , Progresión de la Enfermedad , Método Doble Ciego , Determinación de Punto Final , Femenino , Escala de Coma de Glasgow , Escala de Consecuencias de Glasgow , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Neuroquirúrgicos , Estudios Prospectivos , Pirazoles/efectos adversos , República de Corea , Sulfonamidas/efectos adversos , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
5.
Vet Pathol ; 50(6): 1127-34, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23651736

RESUMEN

Necrotizing meningoencephalitis (NME), necrotizing leukoencephalitis (NLE), and granulomatous meningoencephalomyelitis (GME) are idiopathic inflammatory diseases in the central nervous system (CNS) of dogs. In our previous study, the proportion of inflammatory cells, except for CD3-positive T cells, were not different in parenchymal and perivascular lesions in the brain. However, breed specificities, clinical courses, and specific lesions were distinct among these diseases. Thus, similarities and differences in the pathologies of these diseases have been implied. In this study, the messenger RNA (mRNA) and/or protein expression levels of cytokines and chemokine receptors were investigated in NME (n = 2), NLE (n = 4), and GME (n = 2) cases, and their relationship in the formation of specific lesions was discussed. The mRNA and protein expression levels of interferon (IFN)-γ and interleukin (IL)-17 were marked in NME and GME, respectively. The mRNA expression levels of CXCR3 and CCR2 were also marked in NME and GME, respectively. The results of double-labeling immunofluorescence, used to identify cells producing IL-17 in these lesions, showed that most CD163-positive macrophages/microglia but fewer CD3-positive T cells were IL-17 positive in GME. These results indicate that IFN-γ plays a key role in NME lesions and that the macrophages/microglia that infiltrate brain lesions producing IL-17 are more important in GME than T cells.


Asunto(s)
Encéfalo/patología , Citocinas/metabolismo , Enfermedades de los Perros/patología , Meningoencefalitis/veterinaria , Receptores de Quimiocina/metabolismo , Animales , Encéfalo/inmunología , Encéfalo/metabolismo , Citocinas/genética , Enfermedades de los Perros/inmunología , Perros , Femenino , Interferón gamma/genética , Interferón gamma/metabolismo , Macrófagos/metabolismo , Macrófagos/patología , Masculino , Meningoencefalitis/inmunología , Meningoencefalitis/patología , Necrosis/veterinaria , ARN Mensajero/genética , Receptores de Quimiocina/genética , Linfocitos T Colaboradores-Inductores/inmunología , Linfocitos T Colaboradores-Inductores/metabolismo , Linfocitos T Colaboradores-Inductores/patología
6.
Benef Microbes ; 14(1): 73-84, 2023 Mar 14.
Artículo en Inglés | MEDLINE | ID: mdl-36815493

RESUMEN

When new-born mice are subjected to acute maternal separation stress, cow-milk based formula feeding, and brief recurrent hypoxia with cold stress, they develop gut inflammation similar to the phenotype of neonatal necrotizing enterocolitis, characterised by an increase in gut mucosal effector T (Teffs) and reduced Foxp3+ regulatory T (Tregs) cells. The imbalance can be prevented by probiotic Limosilactobacillus reuteri DSM 17938 (LR 17938). We hypothesised that LR 17938 could potentiate a tolerogenic function of Tregs. To analyse whether LR 17938 can educate Tregs to improve their tolerogenic potency during neonatal stress, we isolated T cells (Tregs and Teffs) from 'donor' mice fed with either LR 17938 (107 cfu) or control media. The cells were adoptively transferred (AT) by intraperitoneal injection (5 × 105 cells/mouse) to new-born (d5) recipient mice. Mice were then separated from their dams, fed formula by gavage, and exposed to hypoxia and cold stress (NeoStress) for 4 days. We analysed the percentage of Tregs in CD4+T helper cells in the intestine (INT) and mesenteric lymph nodes (MLN) of recipient mice. We found that: (1) the percentage of Tregs in the INT and MLN following NeoStress were significantly reduced compared to dam-fed unstressed mice; (2) AT of either naïve Tregs or LR-educated Tregs to mice with Neostress increased the percentage of Tregs in the INT and MLN compared to the percentage in NeoStress mice without Treg treatment; however, LR-educated Tregs increased the Tregs significantly more than naïve Tregs; and (3) AT of LR-educated Tregs reduced pro-inflammatory CD44+Foxp3-NonTregs and inflammatory CX3CR1+ dendritic cells in the intestinal mucosa of NeoStress mice. In conclusion, adoptive transfer of Tregs promotes the generation of and/or migration of endogenous Tregs in the intestinal mucosa of recipient mice. Importantly, probiotic-educated Tregs are more potent than naïve Tregs to enhance immune tolerance following neonatal stress.


Asunto(s)
Probióticos , Linfocitos T Reguladores , Femenino , Bovinos , Ratones , Animales , Privación Materna , Mucosa Intestinal , Tolerancia Inmunológica , Factores de Transcripción Forkhead
7.
Vet Pathol ; 49(4): 682-92, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22262353

RESUMEN

In dogs, there are several idiopathic meningoencephalitides, such as necrotizing meningoencephalitis (NME), necrotizing leukoencephalitis (NLE), and granulomatous meningoencephalomyelitis (GME). Although they are often assumed to be immune mediated, the etiology of these diseases remains elusive. In this study, the histopathology of the lesions caused by these conditions and the inflammatory cell populations produced in response to them were examined among dogs affected with GME, NME, or NLE to understand their pathogeneses. The brain tissues of dogs with NME (n = 25), NLE (n = 5), or GME (n = 9) were used. The inflammatory cells were identified by immunohistochemistry using antibodies against CD3, IgG, CD20, CD79acy, and CD163. In NME and NLE, malacic changes were located in the cerebral cortex, as well as the cerebral white matter and thalamus, respectively. The distribution of the brain lesions in NME and NLE was breed specific. In GME, granulomatous lesions that were mostly composed of epithelioid macrophages were observed in the cerebral white matter, cerebellum, and brainstem. Although the proportions of IgG-, CD20-, and CD79acy-positive cells (B cells) were not significantly different among the GME, NME, and NLE lesions, that of CD3-positive cells (T cells) was increased in GME. In NME and NLE, CD163-positive cells (macrophages) had diffusely infiltrated the cerebral cortex and white matter, respectively. However, in GME, CD163-positive cells accumulated around the blood vessels in the cerebral and cerebellar white matter. The distributions of these lesions were quite different among GME, NME, and NLE, whereas there were no marked differences in the proportions of inflammatory cells.


Asunto(s)
Enfermedades de los Perros/patología , Encefalomielitis/veterinaria , Granuloma/veterinaria , Leucoencefalopatías/veterinaria , Meningoencefalitis/veterinaria , Necrosis/veterinaria , Animales , Antígenos CD/genética , Antígenos CD/metabolismo , Encéfalo/patología , Perros , Encefalomielitis/patología , Regulación de la Expresión Génica , Granuloma/patología , Inmunohistoquímica/veterinaria , Inflamación/patología , Inflamación/veterinaria , Leucoencefalopatías/clasificación , Leucoencefalopatías/patología , Meningoencefalitis/clasificación , Meningoencefalitis/patología , Necrosis/patología
8.
Eur J Gynaecol Oncol ; 33(4): 358-62, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23091890

RESUMEN

OBJECTIVE: The study aimed to investigate expression of p53, p27 and Jun activation domain-binding protein 1 (Jab1) proteins in epithelial ovarian tumors and the values of these factors as discriminating markers for the transformation of borderline tumors to cancers. METHODS: Forty-seven cases of paraffin-embedded tissues of epithelial ovarian tumors including 22 cases of benign ovarian tumors, nine cases of borderline tumors, and 16 cases of invasive cancers were used to evaluate expression of p53, p27 and Jab1 proteins by immunohistochemical methods. RESULTS: p53 protein was expressed in 13.6% of the benign tumors, 44.4% of the borderline tumors and 62.5% of the malignant tumors and p27 protein was expressed in 95.5% of the benign tumors, 66.7% of the borderline tumors, and 37.5% of the malignant tumors. Expression of Jab1 protein was observed in 22.7% of the benign tumors, 77.8% of the borderline tumors and 62.5% of the malignant tumors. Expressions of p53, p27 and Jab1 proteins in malignant tumors were all higher than in benign tumors and the expression of p27 protein in malignant tumors was lower than in benign tumors (p < 0.05). Expression of Jab1 protein in borderline tumors was significantly higher than in benign tumors (p < 0.05). CONCLUSIONS: Expression of p53, p27 and Jab1 proteins can be used to discriminate between benign and malignant tumors in epithelial ovarian tumors.


Asunto(s)
Inhibidor p27 de las Quinasas Dependientes de la Ciclina/análisis , Péptidos y Proteínas de Señalización Intracelular/análisis , Neoplasias Glandulares y Epiteliales/química , Neoplasias Ováricas/química , Péptido Hidrolasas/análisis , Proteína p53 Supresora de Tumor/análisis , Adulto , Complejo del Señalosoma COP9 , Carcinoma Epitelial de Ovario , Femenino , Humanos , Persona de Mediana Edad , Neoplasias Glandulares y Epiteliales/patología , Neoplasias Ováricas/patología
9.
Neuropediatrics ; 42(2): 60-6, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21611937

RESUMEN

OBJECTIVE: Childhood obesity is an emerging health issue in Korea. We investigated the prevalence of obesity and its trend over time in ambulatory Korean children with CP. METHODS: We retrospectively reviewed the medical records of 1,397 children with CP between 1995 and 2008. The data were grouped into 4 time periods (1995-1997, 1998-2002, 2003-2004 and 2005-2008). The prevalence of obesity over each period and its relationship to gender, birth weight, age, and gross motor function classification system were investigated. RESULTS: The percentage of obese children was 5.8%, overweight children 11.2%, and underweight children 10.4%. The prevalence of obesity significantly increased from the first time period to the third time period. The prevalence of obesity found in our study was significantly lower than the report from the U.S.A. during same time period between 1994 and 2004 (p<0.05). The prevalence of obesity significantly decreased with age as well. CONCLUSIONS: The prevalence of obesity in our subjects significantly increased and has reached a plateau in recent years. Compared to the prevalence of childhood obesity in ambulatory individuals with CP in the U.S.A. study, the prevalence in our study was significantly lower.


Asunto(s)
Atención Ambulatoria/estadística & datos numéricos , Parálisis Cerebral/epidemiología , Obesidad/epidemiología , Adolescente , Atención Ambulatoria/métodos , Análisis de Varianza , Niño , Femenino , Humanos , Masculino , Prevalencia , República de Corea/epidemiología , Estudios Retrospectivos
10.
J Appl Microbiol ; 110(5): 1195-202, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21338447

RESUMEN

AIMS: Atopic dermatitis (AD) is marked by elevated levels of immunoglobulin E and skin lesions such as oedema and haemorrhage. Kimchi is a Korean fermented food that contains beneficial bacteria for human health. In this study, Lactobacillus plantarum CJLP55, CJLP56, CJLP133 and CJLP136 isolated from Kimchi were investigated for their capacity to inhibit AD. METHODS AND RESULTS: The three strains, CJLP55, CJLP133 and CJLP136, suppressed AD-like skin lesions, high serum IgE levels and epidermal thickening. The three strains diminished the accumulation of eosinophils and mast cells into topical inflammatory sites and the enlargement of axillary lymph nodes, which are responsible for the dorsal dermatitis. CJLP55, CJLP133 and CJLP136 decreased production of type 2 cytokines such as IL-4 and IL-5 in lymph node cell culture. CJLP133 and CJLP136 increased IFN-γ secretion, while CJLP55 enhanced IL-10 production. CONCLUSIONS: The three strains isolated from Kimchi suppress house-dust mite-induced dermatitis in NC/Nga mouse, a representative animal model of human AD. SIGNIFICANCE AND IMPACT OF THE STUDY: These findings suggest that lactobacilli isolated from Kimchi inhibit AD, probably by altering the balance of Th1/Th2 ratio or inducing IL-10 production.


Asunto(s)
Dermatitis Atópica/terapia , Microbiología de Alimentos , Lactobacillus plantarum/aislamiento & purificación , Probióticos , Piel/patología , Administración Oral , Animales , Brassica/microbiología , Dermatitis Atópica/inmunología , Dermatitis Atópica/patología , Modelos Animales de Enfermedad , Eosinófilos/inmunología , Femenino , Fermentación , Inmunoglobulina E/sangre , Inflamación/patología , Interferón gamma/biosíntesis , Interleucina-10/biosíntesis , Interleucina-4/biosíntesis , Interleucina-5/biosíntesis , Ganglios Linfáticos/patología , Mastocitos/inmunología , Ratones , Pyroglyphidae
11.
Sci Rep ; 10(1): 9497, 2020 Jun 11.
Artículo en Inglés | MEDLINE | ID: mdl-32528160

RESUMEN

Zr-based metallic glasses are prepared by quenching supercooled liquid under pressure. These glasses are stable in ambient conditions after decompression. The High Pressure Quenched glasses have a distinct structure and properties. The pair distribution function shows redistribution of the Zr-Zr interatomic distances and their shift towards smaller values. These glasses exhibit higher density, hardness, elastic modulus, and yield stress. Upon heating at ambient pressure, they show volume expansion and distinct relaxation behavior, reaching an equilibrated state above the glass transition. These experimental results are consistent with an idea of pressure-induced low to high density liquid transition in the supercooled melt.

12.
Neuropediatrics ; 40(6): 298-300, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20446227

RESUMEN

Here, we report on a boy affected by both cerebral palsy and Becker muscular dystrophy (BMD). He had infrequently used his right hand since birth. But brain magnetic resonance imaging (MRI) taken at the age of 15 months showed no specific finding. Approximately 1 month later, muscle enzymes of his older brother were incidentally found to be elevated. The patient and his brother were diagnosed with progressive muscular dystrophy by gene analysis. At the age of 6 years, he underwent orthopedic surgery due to a right equinovarus deformity and BMD was confirmed by concomitant muscle biopsy. During the post-operative rehabilitation, clumsiness of the right hand was also observed. A follow-up brain MRI with diffusion tensor imaging (DTI) was taken. Although no responsible lesion was found on conventional MRI, DTI and fiber tractography revealed a decrease in the quantity of fibers in the left corticospinal tract. He was additionally diagnosed as having cerebral palsy.


Asunto(s)
Lesiones Encefálicas/diagnóstico , Lesiones Encefálicas/etiología , Corteza Cerebral/patología , Distrofia Muscular de Duchenne/complicaciones , Tobillo/inervación , Tobillo/fisiopatología , Fenómenos Biomecánicos , Humanos , Lactante , Rodilla/inervación , Rodilla/fisiopatología , Masculino , Músculo Esquelético/patología
13.
Neuropediatrics ; 40(6): 269-74, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20446220

RESUMEN

OBJECTIVE: The aim of this study was to investigate whether modified constraint-induced movement therapy (mCIMT) following a botulinum type A toxin (BoNT-A) injection enhances the effects of the BoNT-A injection into the spastic upper limb of children with hemiplegic cerebral palsy (CP). METHODS: A combined therapy with mCIMT and BoNT-A was given to 17 children in group A. Fifteen children in group B received only the BoNT-A injection. The muscle tone, the movement pattern, and the How Often and the How Well scales in the revised Pediatric Motor Activity Log (revised PMAL) were assessed before and 3 weeks after intervention. RESULTS: Three participants in group A dropped out due to poor tolerance of mCIMT. There were significant improvements in the muscle tone and the movement patterns for both groups (p<0.05), and the changes were not significantly different between the two groups. The How Often and the How Well scales in the revised PMAL were significantly improved in group A (p<0.05), but not in group B. CONCLUSION: A combined therapy of mCIMT and BoNT-A seems to be helpful to enhance the effects of the BoNT-A injection in the functional use of the affected limb in children with hemiplegic CP.


Asunto(s)
Toxinas Botulínicas Tipo A/uso terapéutico , Parálisis Cerebral/tratamiento farmacológico , Parálisis Cerebral/rehabilitación , Terapia por Ejercicio/métodos , Fármacos Neuromusculares/uso terapéutico , Restricción Física/métodos , Parálisis Cerebral/complicaciones , Niño , Preescolar , Evaluación de la Discapacidad , Femenino , Humanos , Lactante , Masculino , Actividad Motora/fisiología , Examen Neurológico , Modalidades de Fisioterapia , Resultado del Tratamiento
14.
Sci Rep ; 9(1): 18579, 2019 Dec 09.
Artículo en Inglés | MEDLINE | ID: mdl-31819088

RESUMEN

We present the results of a structural study of metallic alloy liquids from high temperature through the glass transition. We use high energy X-ray scattering and electro-static levitation in combination with molecular dynamics simulation and show that the height of the first peak of the structure function, S(Q) - 1, follows the Curie-Weiss law. The structural coherence length is proportional to the height of the first peak, and we suggest that its increase with cooling may be related to the rapid increase in viscosity. The Curie temperature is negative, implying an analogy with spin-glass. The Curie-Weiss behavior provides a pathway to an ideal glass state, a state with long-range correlation without lattice periodicity, which is characterized by highly diverse local structures, reminiscent of spin-glass.

16.
Int J Tuberc Lung Dis ; 22(11): 1336-1343, 2018 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-30355414

RESUMEN

OBJECTIVE: To evaluate the acceptance of, adherence to, and outcomes of latent tuberculous infection (LTBI) treatment among health care workers (HCWs). DESIGN: This was a retrospective study in a tertiary hospital in Korea. From May to August 2017, 2190 HCWs simultaneously underwent a tuberculin skin test (TST) and interferon-gamma release assay (IGRA). LTBI was diagnosed if the TST induration was 10 mm or IGRA results were positive. RESULTS: Of 2190 HCWs tested, 1006 (45.9%) were diagnosed with LTBI. Of these, 655 (65.1%) HCWs visited out-patient clinics, 234 (35.7%) of whom were advised treatment by physicians. Among these, 120 (51.3%) accepted the physicians' recommendations. In general, HCWs who were older, male and smoked were less likely to visit out-patient clinics. Sixty (50%) HCWs received 3 months of isoniazid plus rifampicin (3HR) and 57 (47.5%) HCWs received 4 months of rifampicin (4R). The proportion of HCWs with 2 side effects (3HR 20% vs. 4R 7.0%, P = 0.041) and drug stoppage rate (3HR 20% vs. 4R 5.3%, P = 0.017) were higher in the 3HR group than in the 4R group. Of the 120 HCWs, 78 (65%) completed LTBI treatment. CONCLUSION: Overall, the acceptance and completion rate for LTBI treatment was not adequate. For effective LTBI management in HCWs, further programmatic strategies are needed.


Asunto(s)
Antibióticos Antituberculosos/uso terapéutico , Personal de Salud/estadística & datos numéricos , Tuberculosis Latente/tratamiento farmacológico , Tuberculosis Latente/epidemiología , Cumplimiento de la Medicación/estadística & datos numéricos , Adulto , Antibióticos Antituberculosos/efectos adversos , Esquema de Medicación , Quimioterapia Combinada , Femenino , Humanos , Ensayos de Liberación de Interferón gamma , Isoniazida/uso terapéutico , Tuberculosis Latente/diagnóstico , Masculino , Persona de Mediana Edad , República de Corea/epidemiología , Estudios Retrospectivos , Rifampin/uso terapéutico , Centros de Atención Terciaria , Prueba de Tuberculina , Adulto Joven
17.
Cell Death Differ ; 13(9): 1541-53, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16410805

RESUMEN

Type I interferons (IFN-alpha/-beta) are capable of suppressing c-myc mRNA expression by modulating post-transcriptional processing. However, the molecular mechanism of this phenomenon is poorly understood. We previously established that human polynucleotide phosphorylase (hPNPase(old-35)), a type I IFN-inducible 3',5' exoribonuclease involved in mRNA degradation, induces G1 cell cycle arrest and eventually apoptosis by specifically degrading c-myc mRNA. We now demonstrate a close association between IFN-beta-induced hPNPase(old-35) upregulation and c-myc downregulation in human melanoma cells. Employing stable melanoma cell clones expressing hPNPase(old-35) small inhibitory RNA, we demonstrate that hPNPase(old-35) is a key molecule coupled with IFN-beta-mediated downregulation of c-myc mRNA. Inhibition of hPNPase(old-35) or overexpression of c-myc protects melanoma cells from IFN-beta-mediated growth inhibition, emphasizing the importance of hPNPase(old-35) upregulation and consequent c-myc downregulation in IFN-beta-induced growth inhibition and apoptosis induction. In these contexts, targeted overexpression of hPNPase(old-35) might be a novel therapeutic strategy for c-myc-overexpressing and IFN-resistant tumors, such as melanomas.


Asunto(s)
Exorribonucleasas/metabolismo , Interferón beta/fisiología , Melanoma/metabolismo , Proteínas Proto-Oncogénicas c-myc/biosíntesis , Apoptosis , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Regulación hacia Abajo , Exorribonucleasas/genética , Humanos , Interferón beta/farmacología , Melanocitos/metabolismo , Proteínas Proto-Oncogénicas c-myc/genética , ARN Interferente Pequeño/biosíntesis
18.
Neuroscience ; 146(3): 1128-36, 2007 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-17395388

RESUMEN

The present study was undertaken to characterize the regional and temporal patterns of brain-derived neurotrophic factor (BDNF) in the rat forebrain and upper brain stem during postnatal development using an immunohistochemical approach. Results indicated that BDNF-immunoreactive (IR) cells could be divided into three groups based on their postnatal developmental patterns: (group 1) BDNF-IR cells were first detected between postnatal days (PND) 1 and 7, and thereafter they increased in number and remained stable during later stages of ontogeny; (group 2) BDNF-IR cells progressively increased in number with age, and then decreased in adults; (group 3) numerous BDNF-IR cells detected between PND 1 and 7 showed a dramatic reductions in number with few IR cells in adults. In contrast, the developmental pattern of most BDNF-IR fibers differed from that of IR neurons, i.e. they appeared between PND 1-28 and thereafter continued to increase in number showing a maximum level in adults. Additionally, BDNF-IR cells in the superficial layer of the neocortex and IR fibers in the stratum oriens of CA2 first appeared as late as PND 28 and in adults, respectively. After colchicine treatment, reexpression or a marked increase in the number of BDNF-IR neurons was observed in many areas of the adult brain where a progressive decrease in BDNF-IR cell numbers during development and scant or some IR neurons in adults were shown. These results showed both transient and persistent expression of BDNF in various regions of the developing rat brain.


Asunto(s)
Animales Recién Nacidos/fisiología , Tronco Encefálico/metabolismo , Factor Neurotrófico Derivado del Encéfalo/biosíntesis , Prosencéfalo/metabolismo , Animales , Tronco Encefálico/citología , Tronco Encefálico/crecimiento & desarrollo , Recuento de Células , Colchicina/farmacología , Diencéfalo/crecimiento & desarrollo , Diencéfalo/metabolismo , Inmunohistoquímica , Masculino , Mesencéfalo/crecimiento & desarrollo , Mesencéfalo/metabolismo , Fibras Nerviosas/metabolismo , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Prosencéfalo/citología , Prosencéfalo/crecimiento & desarrollo , Ratas , Ratas Sprague-Dawley , Telencéfalo/crecimiento & desarrollo , Telencéfalo/metabolismo
19.
Artículo en Inglés | MEDLINE | ID: mdl-17951119

RESUMEN

A simple, rapid, sensitive and specific liquid chromatography-tandem mass spectrometry method was developed and validated for quantification of beraprost, a stable, orally active prostacyclin analogue with vasodilatory, antiplatelet and cytoprotective effects. The analyte and internal standard, indomethacin, were extracted by solid-phase extraction using OASIS HLB cartridge. The chromatographic separation was performed on a C18 column with a mobile of 0.1% formic acid-methanol (30:70, v/v). The highest daughter ion of deprotonated analyte was quantitated in negative ionization by multiple reactions monitoring with a mass spectrometer. The mass transitions m/z 397>269 and m/z 356>312 were used to measure beraprost and internal standard, respectively. The assay exhibited a linear range from 0.02 to 2 ng/mL for beraprost in human plasma. The lower limit of quantitation was 20 pg/mL with a relative standard deviation of less than 20%. The method was validated with respect to linearity, sensitivity, specificity, recovery, accuracy and precision. The validated method has been successfully used to analyze human plasma samples for application in pharmacokinetic study.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Epoprostenol/análogos & derivados , Espectrometría de Masas en Tándem/métodos , Epoprostenol/sangre , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
20.
Mol Endocrinol ; 14(3): 440-8, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10707961

RESUMEN

TSH has multiple physiological roles: it is required for growth, differentiation, and function of the thyroid gland, and it regulates transcription of interferon-gamma (IFN-gamma)-responsive genes in thyrocytes, including genes for the major histocompatibility complex and intercellular adhesion molecule-1. This report demonstrates that TSH induces the expression of suppressor of cytokine signaling (SOCS)-1 and -3 proteins and alters the phosphorylation state of signal transducer and activator of transcription (STAT) proteins STAT1 and STAT3. The expression of SOCS-1 and SOCS-3 and the phosphorylation state of STAT1 and STAT3 were examined after treatment with TSH or IFN-gamma in either TSH-sensitive FRTL-5 thyroid cells or TSH-insensitive FRT and buffalo rat liver (BRL) cells, which lack functional TSH receptors. SOCS-1 and SOCS-3 are constitutively expressed in FRTL-5 cells, but not in FRT and BRL cells. IFN-gamma up-regulated SOCS-1 and SOCS-3 RNA and protein in FRTL-5 cells, as reported previously for nonthyroid cells. Interestingly, TSH also significantly induced SOCS-1 and SOCS-3 in FRTL-5 cells, but not in FRT and BRL cells. When SOCS-1 or SOCS-3 was overexpressed in FRTL-5 cells, STAT1 phosphorylation at Y701 and STAT1/DNA complex formation in response to IFN-gamma were reduced. Furthermore, overexpression of either SOCS-1 or SOCS-3 significantly inhibited the IFN-gamma-mediated transactivation of the rat ICAM-1 (intercellular adhesion molecule-1) promoter. TSH and IFN-gamma had different effects on STAT1 and STAT3 phosphorylation. The phosphorylation of Y701 in STAT1, which is responsible for homodimer formation, nuclear translocation, and DNA binding, was specifically stimulated by IFN-gamma, but not by TSH or forskolin. However, the phosphorylation of S727 in STAT1 was induced by IFN-gamma, TSH, and forskolin. TSH induced phosphorylation of both Y705 and S727 in STAT3, while IFN-gamma phosphorylated only the Y705. In addition, we found that SOCS-3 was associated with JAK1 and JAK2 and that these associations were stimulated by TSH. These findings demonstrate that TSH induces SOCS in thyroid cells and provides the evidence of signal cross-talk between TSH and cytokines in thyroid cells.


Asunto(s)
Proteínas Portadoras/biosíntesis , Péptidos y Proteínas de Señalización Intracelular , Biosíntesis de Proteínas , Proteínas Represoras , Transducción de Señal/efectos de los fármacos , Glándula Tiroides/efectos de los fármacos , Tirotropina/farmacología , Factores de Transcripción , Animales , Antitiroideos/farmacología , Proteínas Portadoras/genética , Línea Celular , Colforsina/farmacología , Proteínas de Unión al ADN/metabolismo , Humanos , Proteínas Inmediatas-Precoces/biosíntesis , Proteínas Inmediatas-Precoces/genética , Interferón gamma/farmacología , Hígado/efectos de los fármacos , Hígado/metabolismo , Metimazol/farmacología , Fosforilación/efectos de los fármacos , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Tirosina Quinasas/metabolismo , Proteínas/genética , Ratas , Proteínas Recombinantes , Factor de Transcripción STAT1 , Factor de Transcripción STAT3 , Proteína 1 Supresora de la Señalización de Citocinas , Proteína 3 Supresora de la Señalización de Citocinas , Proteínas Supresoras de la Señalización de Citocinas , Glándula Tiroides/metabolismo , Transactivadores/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA